首页
400-620-6333
应用
选项
-
Recombinant Human BTN3A2 Protein
- 种属: 人(Human)
- Accession #: P78410
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <0.1 EU/μg
- 生物活性: Measured by its ability to enhance anti-CD3-induced IFN-gamma secretion of mouse CD3+ T cells. The ED50 for this effect is 0.5-2.5 μg/mL.
-
Recombinant Mouse TNF RII/TNFRSF1B Protein
- 种属: 小鼠(Mouse)
- Accession #: P25119
- 表达系统: HEK293
- 蛋白标签: C-hFc & His
- 内毒素水平: <0.1 EU/μg
- 生物活性: Measured in a cytotoxicity assay using L929 mouse fibrosarcoma cells in the presence of the metabolic inhibitor actinomycin D (A113142). The ED50 for this effect is typically 0.95 ng/mL in the presence of 0.5 ng/mL of Recombinant Mouse TNF-alpha Protein (rp154759).
-
Recombinant Mouse OX40 Ligand/TNFSF4 Protein
- 种属: 小鼠(Mouse)
- Accession #: P43488
- 表达系统: HEK293
- 蛋白标签: N-10His
- 内毒素水平: <0.1 EU/μg
- 生物活性: Measured by its ability to co-stimulate IL-2 secretion by mouse T cells in the presence of anti-CD3. The ED50 for this effect is 10-30 ng/mL in the presence of a cross-linking antibody, Mouse Anti-polyHistidine Monoclonal Antibody.
-
Recombinant Human LAIR1 Protein
- 种属: 人(Human)
- Accession #: Q6GTX8
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <0.1 EU/μg
- 生物活性: Measured by the ability of the immobilized protein to support the adhesion of HeLa human cervical epithelial carcinoma cells. The ED50 for this effect is 0.25-1.0 μg/mL.
-
Recombinant Human Siglec-15 Protein
- 种属: 人(Human)
- Accession #: Q6ZMC9-1
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <0.1 EU/μg
- 生物活性: Measured by its ability to inhibit anti-CD3 antibody induced IL-2 or IFN-gamma secretion by human T cells. The ED50 for this effect is 1-10 μg/mL.
-
Recombinant Human TrkC Protein
- 种属: 人(Human)
- Accession #: Q96CY4
- 表达系统: HEK293
- 蛋白标签: C-hFc & His
- 内毒素水平: <0.1 EU/μg
- 生物活性: Measured by its ability to inhibit NT-3-induced proliferation of BaF‑TrkB‑BD mouse pro‑B cells transfected with TrkB. The ED50 for this effect is 0.05-0.2 µg/mL in the presence of 40 ng/mL of rhNT-3.
-
Recombinant Human Neuronal Pentraxin 2 Protein
- 种属: 人(Human)
- Accession #: P47972
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <0.1 EU/μg
- 生物活性: Measured by the ability of the immobilized protein to support the adhesion of TT human medullary thyroid cancer cells. The ED50 for this effect is 0.6‑2.4 μg/mL.
-
Recombinant Mouse Activin RIIB Protein
- 种属: 小鼠(Mouse)
- Accession #: P27040
- 表达系统: HEK293
- 蛋白标签: C-hFc & His
- 内毒素水平: <0.1 EU/μg
- 生物活性: Measured by its ability to inhibit Activin A-induced hemoglobin expression in K562 human chronic myelogenous leukemia cells. The ED50 for this effect is 5-30 ng/mL in the presence of 3 ng/mL of recombinant human Activin A.
-
Recombinant Mouse CD47 Protein
- 种属: 小鼠(Mouse)
- Accession #: NP_034711
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <0.1 EU/μg
- 生物活性: Measured by its binding ability in a functional ELISA. When Recombinant Mouse SIRP alpha /CD172a Fc Chimera is coated at 2 μg/mL, Recombinant Mouse CD47 binds with an apparent Kd <0.6 nM. Also measured by its ability to antagonize mouse red blood cell adhesion to immobilized Recombinant Mouse SIRP alpha /CD172a Fc Chimera. The ED50 for this effect is 2.0-8.0 μg/mL. Optimal dilutions should be determined by each laboratory for each application.
-
Recombinant Mouse gp130 Protein
- 种属: 小鼠(Mouse)
- Accession #: Q6PDI9
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <0.1 EU/μg
- 生物活性: Measured by its ability to inhibit IL-6-dependent proliferation of the 7TD1 mouse hybridoma cells in the presence of Recombinant Human IL-6 R alpha. The ED50 for this effect is 1.8 ng/mL.
-
Recombinant Mouse TGF-beta RII Protein
- 种属: 小鼠(Mouse)
- Accession #: Q62312-1
- 表达系统: HEK293
- 蛋白标签: C-hFc & His
- 内毒素水平: <0.1 EU/μg
- 生物活性: Measured by its ability to inhibit TGF-beta 1 activity on HT 2 mouse T cells. The ED50 for this effect is 3-10 ng/mL in the presence of 1 ng/mL of rhTGF-beta 1.
-
Recombinant Mouse IL-1 RI Protein
- 种属: 小鼠(Mouse)
- Accession #: P13504-1
- 表达系统: HEK293
- 蛋白标签: C-His
- 内毒素水平: <0.1 EU/μg
- 生物活性: Measured by its ability to inhibit IL-1 alpha -dependent proliferation in D10.G4.1 mouse helper T cells. Approximately 0.005‑0.015 µg/mL of IL-1 sRI will inhibit 50% of the biological response due to 50 pg/mL of rmIL-1a.
